BreatheSuite is a Canadian connected health company founded in 2018 to help people with chronic respiratory conditions live longer, healthier lives. The BreatheSuite MDI device, which received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for prescription and over-the-counter use, is compatible with 90% of MDIs on the market to track and train proper inhaler usage. Coupled with a mobile application built on behavior change strategies, it provides tips to improve inhaler adherence and technique, and enables remote patient monitoring. Also cleared for sale in Canada, BreatheSuite works

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved